SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-004333
Filing Date
2020-06-08
Accepted
2020-06-08 18:15:15
Documents
1
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4104
  Complete submission text file 0001562180-20-004333.txt   5473
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142
Business Address
Audia James E (Reporting) CIK: 0001746115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 20950344